Health-e News

Who controls South Africa’s lenacapavir rollout? Not South Africa

South Africa may build the factories for lenacapavir, but licensing decisions, pricing, and supply remain dependent on Gilead, exposing the limits of sovereignty in global health.

This post Who controls South Africa’s lenacapavir rollout? Not South Africa first appeared on Health-e News and is written by Health-e News

Comment

Your email address will not be published. Required fields are marked *